iRhythm Technologies, Inc. (IRTC) は上場企業です ヘルスケア セクターの Medical - Devices 業界で事業展開. 本社所在地は San Francisco, CA, アメリカ. 現CEOは Quentin S. Blackford.
IRTC を有する IPO日 2016-10-20, 2,000 名の正社員, に上場 NASDAQ Global Select, 時価総額 $3.98B.
iRhythm Technologies, Inc. is a digital healthcare company headquartered in San Francisco that specializes in ambulatory electrocardiogram (ECG) monitoring solutions for patients at risk of arrhythmias in the United States. The company's flagship Zio service combines wire-free, patch-based wearable biosensors with a cloud-based analytics platform to enable physicians to continuously monitor patients and diagnose cardiac arrhythmias. Its Zio XT and AT monitors are single-use, wearable patches that record patient heartbeats and ECG data for clinical analysis. iRhythm also collaborates with Verily Life Sciences to develop next-generation atrial fibrillation detection and monitoring products, positioning itself at the intersection of wearable technology and cardiac care.
